Beatriz Mota
The impact of new therapies on clinical decision-making: update on therapies with monoclonal antibodies
- Integrated Master’s Degree in Medicine at the Faculty of Medicine, University of Porto (2012–2018)
- General Training Internship at Centro Hospitalar Lisboa Ocidental (2019)
- Specialized Training Internship in Stomatology at the ULS Santa Maria (2020–2024)
- Postgraduate Program in TMJ Arthroscopy and Open Surgery of the Temporomandibular Joint – Organized by the Faculty of Medicine, University of Lisbon (2021)
- Postgraduate Program in Aesthetic Medicine – Organized by the University of Alcalá, Madrid, and recognized by the Portuguese Society of Aesthetic Medicine and the Spanish Society of Aesthetic Medicine (2021/2022)
- Postgraduate Program in Health Administration and Management – Organized by the Instituto Superior de Ciências Sociais e Políticas (ISCSP) and the Faculty of Medicine, University of Lisbon (2022/2023)
- Maxillofacial Surgery Internship at Sírio-Libanês Hospital and Albert Einstein Israelite Hospital, São Paulo, Brazil (2023)
- Doctor in Stomatology Department at the ULS Santa Maria (2024–Present)
- Doctor at Instituto Português da Face (2024–Present)
- Several publications in indexed journals and oral presentations at international conferences within the specialty
Nationality: Portugal
Scientific areas: Therapeutics
7 of november, from 15h05 until 15h40
Room 1
Conference summary
Monoclonal antibodies are a group of medications with diverse and increasing therapeutic applications. They are used in the treatment of various diseases, being an important tool in various oncological, inflammatory, autoimmune diseases, among others.
Despite their specificity and good tolerability, monoclonal antibodies have documented adverse effects, including oral and maxillofacial complications. There are several complications, notably Medication-Related Osteonecrosis of the Jaw, which may require drug-holiday or even discontinuation of the treatment.
The treatment of these complications is multidisciplinary, may be either with a conservative or surgical approach, depending on the extent and severity of the disease. The primary goal is always pain and infection control, aiming to reduce morbidity and improve the patient’s quality of life.